-
May 23, 2024 | 
eyetube.net | Ramin Tadayoni |Carl D. Regillo
Clinical Minute Retina: PPV for VH Secondary to RVO Ramin Tadayoni, MD, PhD and Carl Regillo, MD Show Description + How useful is vitrectomy to address vitreous hemorrhage (VH) secondary to retinal vein occlusion (RVO)? Clinical Minute: Retina founding host Ramin Tadayoni, MD, PhD, sits down with Carl Regillo, MD, to review the findings from a recent study he co-authored, and explores the depth and breadth of complications that may occur after vitrectomy for VH secondary to RVO.
-
May 4, 2024 | 
healio.com | Michela Cimberle |Christine Klimanskis |Ramin Tadayoni
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Ramin Tadayoni, MD, PhD, newly elected president of the European Society of Retina Specialists and highly esteemed member of the global retina community, died unexpectedly on April 20.
-
Feb 29, 2024 | 
eyetube.net | Ramin Tadayoni |Arshad Khanani
GATHER2 Data at 1 and 2 Years Ramin Tadayoni, MD, PhD and Arshad Khanani, MD, MA Show Description + What are the most important data to know from the GATHER2 study? Clinical Minute: Retina host Ramin Tadayoni, MD, PhD, is joined by Arshad Khanani, MD, MA, to review the 1- and 2-year results of the GATHER2 study. At the end of the episode, Dr. Khanani shares his framework for successful work.
-
Dec 6, 2023 | 
healio.com | Ramin Tadayoni |Michela Cimberle |Christine Klimanskis
Read more You've successfully added Ophthalmology: Retina/Vitreous to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
-
Nov 14, 2023 | 
eyetube.net | Ramin Tadayoni |Arshad Khanani |David S. Boyer
OCS-01 Eye Drops, A Potentially Transformative Treatment Option for DME Ramin Tadayoni, MD, PhD; Arshad M. Khanani, MD; David S. Boyer, MD Show Description + In this panel discussion, three retina experts discuss the need for pre-invasive treatment options to manage patients with newly diagnosed diabetic macular edema (DME) many of whom currently go untreated.
-
Nov 9, 2023 | 
eyetube.net | Diana V Do |Ramin Tadayoni
Response to Protocol V: Is Observation a Wise Approach to DME with 20/25 Vision? Diana Do, MD, and Ramin Tadayoni, MD, PhD Show Description + The DRCR Retina Network's Protocol V study found that, in eyes with at least 20/25 VA and DME, observation was appropriate until visual decline occurred. To Diana Do, MD, and colleagues, it wasn't that simple.
-
Sep 8, 2023 | 
eyetube.net | Ramin Tadayoni |Frank G. Holz
Biosimilars in Retina Ramin Tadayoni, MD, PhD, and Prof. Frank Holz Show Description + As we enter the era of biosimilars in retina, Clinical Minute: Retina host Ramin Tadayoni, MD, PhD, invites Prof. Frank Holz to update viewers on the state of biosimilars in retina. They discuss what biosimilars are, how they are approved, whether they might offer cost savings to health care systems, and which markets might be best suited for rapid biosimilar adoption.
-
Sep 5, 2023 | 
bjo.bmj.com | David Sarraf |Arshad Khanani |Ramin Tadayoni |Andrew Chang
Introduction Subretinal hyper-reflective material (SHRM), identified on optical coherence tomography (OCT) as hyper-reflective material located between the neurosensory retina and retinal pigment epithelium (RPE), is common in eyes with neovascular age-related macular degeneration (nAMD) and often persists following antivascular endothelial growth factor (VEGF) treatment.1–4 SHRM components are poorly understood and assumed to vary both temporally and according to neovascular subtype, or...
-
Jul 14, 2023 | 
eyetube.net | María H. Berrocal |Ramin Tadayoni
PPV vs Conventional Therapy for PDR María H. Berrocal, MD, and Ramin Tadayoni, MD, PhD Show Description + What were the long-term outcomes of patients with bilateral proliferative diabetic retinopathy who underwent vitrectomy in one eye and conventional therapy in the contralateral eye? María H. Berrocal, MD, joins Clinical Minute: Retina host Ramin Tadayoni, MD, PhD, to discuss the findings of her recent paper that explored this question in 64 real-world patients.
-
Jun 12, 2023 | 
eyetube.net | Ramin Tadayoni |Allen Ho
ALOFT Study: Value of False Positive Alerts in Home Monitoring for Wet AMD Conversion Ramin Tadayoni, MD, PhD, and Allen C. Ho, MD What was the link between false positive alerts and eventual conversion to wet AMD among patients in the ALOFT study, which assessed the efficacy of a home monitoring strategy using the ForeseeHome (Notal Vision) in patients with intermediate AMD? Allen C.
